J. Unkerskov

Systematic Medication Review in General Practice by an Interdisciplinary Team: A thorough but Laborious Method to Address Polypharmacy among Elderly Patients

C. Vermehren, J. T. Andersen, A. K. Jensen, 2020, Pharmacy.

Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO)

U. Tarp, M. Østergaard, M. Hetland, 2005, Scandinavian journal of rheumatology.

Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?

M. Østergaard, J. Pødenphant, U. Tarp, 2007, Annals of the rheumatic diseases.

Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database

M. Østergaard, U. Tarp, M. Østergaard, 2007, Scandinavian journal of rheumatology.

Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry

M. Østergaard, J. Pødenphant, U. Tarp, 2008, Annals of the rheumatic diseases.